• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs

    6/30/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email

    -- Experienced Industry Leader to drive Cosette's Best-in-Class Quality Organization and facilitate Regulatory Approvals --

    Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630266171/en/

    Jeff Neubig, VP, Quality & Regulatory Affairs, Cosette Pharmaceuticals

    Jeff Neubig, VP, Quality & Regulatory Affairs, Cosette Pharmaceuticals

    In this critical role, Jeff will lead Cosette's best-in-class quality and regulatory affairs organizations, maintaining the company's rigorous quality standards and further establishing Cosette's strong position as a respected and reliable supplier of high-quality medicines.

    "We are thrilled to add an experienced quality and regulatory leader like Jeff to Cosette, further establishing our unwavering commitment to delivering high quality, reliable products that has resulted in 24 new product launches over the last three years with zero major quality observations," said Apurva Saraf, President and CEO, Cosette Pharmaceuticals. "As we scale our business exponentially, Jeff's proven track record in quality leadership and regulatory strategy will be instrumental in delivering affordable and accessible therapies with speed and precision."

    Prior to joining Cosette, Jeff served as Vice President of Quality and Regulatory Affairs, North America at LTS Lohmann Therapy Systems, where he successfully oversaw multiple regulatory inspections with zero observations, provided regulatory guidance and wrote filings for IND, NDA and ANDA products, and led tech transfer and validation teams, among other achievements.

    "I'm excited to be joining Cosette at this time of strong momentum and progress to help bring critical therapies to patients," said Jeff Neubig, Vice President, Quality and Regulatory Affairs, Cosette Pharmaceuticals. "Cosette is widely known and respected for being a high-quality, reliable supplier of medicines. I'm thrilled to help advance that important work and lay the foundation for continued long-term growth."

    Jeff brings over 35 years of experience in the pharmaceutical industry to Cosette, including over 25 years leading quality assurance, quality control and regulatory affairs teams, working with products from pre-clinical development all the way through commercial operations. He has worked in companies specializing in transdermal patches, oral thin films, liquid formulations, sterile injectables and solid oral dosage forms.

    Jeff earned a Ph.D. in Evolution, Ecology and Organismal Biology from The Ohio State University, an MS in Biology from Montclair State University, and a Bachelor's degree in Biology from Mount Saint Mary's College.

    About Cosette Pharmaceuticals

    Cosette Pharmaceuticals, Inc. is a U.S.-based, fully integrated pharmaceutical company with a fast-growing portfolio of products in women's health and dermatology. Cosette has a long history in quality manufacturing of complex dosage forms including topical creams, ointments, oral liquids/solutions and suppositories. Cosette has corporate and manufacturing facilities in New Jersey and North Carolina and is supported by 350+ dedicated team members across all functional areas. Cosette is backed by Avista Healthcare Partners, a healthcare focused private equity firm, and funds managed by Hamilton Lane, a private markets investment management firm (NASDAQ:HLNE). For more information, please visit www.cosettepharma.com or follow Cosette on LinkedIn.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250630266171/en/

    Cosette Pharmaceuticals:

    Media:

    [email protected]

    Get the next $HLNE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    10/14/2025$181.00Perform → Outperform
    Oppenheimer
    10/13/2025$150.00Mkt Perform → Outperform
    Keefe Bruyette
    10/3/2025$150.00Outperform
    BMO Capital Markets
    9/18/2025$162.00Sell → Neutral
    Goldman
    5/15/2025Outperform → Perform
    Oppenheimer
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    1/6/2025$139.00Neutral → Sell
    Goldman
    9/12/2024$156.00Equal Weight
    Wells Fargo
    More analyst ratings

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hamilton Lane Tokenized Private Credit Fund Launches on Sei Network via KAIO's Institutional-grade Infrastructure

    -       KAIO has been leading the tokenization of major institutional funds, expanding crypto-native access to regulated money markets and alternative investment strategies -       The tokenization of Hamilton Lane SCOPE Fund on Sei's DeFi optimized design is expected to enhance accessibility for the fund's investors ABU DHABI, UAE, Oct. 15, 2025 /PRNewswire/ -- KAIO, the leading fully onchain infrastructure for regulated real-world assets (RWAs), today announced the expansion of its tokenized fund offerings on the Sei Network by bringing access to Hamilton Lane's (NASDAQ:HLNE) Senior Credit Opportunities Fund ("SCOPE") onchain, via HL SCOPE Access Fund1, for institutional and accredited inv

    10/15/25 9:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated to Announce Second Quarter Fiscal 2026 Results on November 4, 2025

    CONSHOHOCKEN, Pa., Oct. 14, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the second fiscal quarter ended September 30, 2025 before the market opens on Tuesday, November 4, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 10:00 a.m. ET on November 4 to discuss the results for the second fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://shareholders.hamiltonlane.com/) at lea

    10/14/25 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Novata Acquires Atlas Metrics to Power the Future of Sustainability Data Management

    Backed by a new funding round led by S&P Global, Novata is defining the next era of sustainability data for private markets Novata, a leading sustainability data management platform for private markets, today announced the acquisition of Atlas Metrics, a top European sustainability performance and reporting platform. This strategic move expands Novata's global reach and unites two complementary companies to meet the growing demand from investors and corporates for trusted, efficient, and scalable sustainability data solutions. Together, Novata and Atlas Metrics now supports more than 400 clients and 13K+ companies worldwide, equipping investors, banks, and corporates with the tools th

    10/7/25 7:10:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/13/24 4:31:06 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hamilton Lane upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $181.00

    10/14/25 8:37:36 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Hamilton Lane from Mkt Perform to Outperform and set a new price target of $150.00

    10/13/25 8:40:10 AM ET
    $HLNE
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Hamilton Lane with a new price target

    BMO Capital Markets initiated coverage of Hamilton Lane with a rating of Outperform and set a new price target of $150.00

    10/3/25 8:40:27 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Mcallister Margaret Anne claimed ownership of 59,006 shares and claimed ownership of 300,000 units of Class B Common Stock (SEC Form 3)

    3 - Hamilton Lane INC (0001433642) (Issuer)

    9/18/25 5:03:07 PM ET
    $HLNE
    Investment Managers
    Finance

    Director Sexton O Griffith was granted 1,331 shares, increasing direct ownership by 38% to 4,852 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    9/18/25 5:01:35 PM ET
    $HLNE
    Investment Managers
    Finance

    Director Varon Leslie F was granted 666 shares, increasing direct ownership by 7% to 9,658 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    9/18/25 5:00:52 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    SEC Filings

    View All

    Hamilton Lane Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Hamilton Lane INC (0001433642) (Filer)

    10/6/25 4:23:40 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Hamilton Lane INC (0001433642) (Filer)

    9/5/25 4:29:27 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Hamilton Lane INC (0001433642) (Filer)

    9/4/25 4:16:11 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    View All

    Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs

    -- Experienced Industry Leader to drive Cosette's Best-in-Class Quality Organization and facilitate Regulatory Approvals -- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630266171/en/Jeff Neubig, VP, Quality & Regulatory Affairs, Cosette Pharmaceuticals In this critical role, Jeff will lead Cosette's best-in-class quality and regulatory affairs organizations, maintaining the company's rigorous quality standards and further establishing Co

    6/30/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

    Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

    4/23/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations

    Industry leader with 35+ years of experience in manufacturing operations and global supply chain excellence Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Vincent (Vin) Colicchio as Senior Vice President of Operations, effective February 3, 2025. In this role, Vin will lead Cosette's manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210366017/en/Senior Vice President, Operations (Photo

    2/10/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Financials

    Live finance-specific insights

    View All

    Hamilton Lane Tokenized Private Credit Fund Launches on Sei Network via KAIO's Institutional-grade Infrastructure

    -       KAIO has been leading the tokenization of major institutional funds, expanding crypto-native access to regulated money markets and alternative investment strategies -       The tokenization of Hamilton Lane SCOPE Fund on Sei's DeFi optimized design is expected to enhance accessibility for the fund's investors ABU DHABI, UAE, Oct. 15, 2025 /PRNewswire/ -- KAIO, the leading fully onchain infrastructure for regulated real-world assets (RWAs), today announced the expansion of its tokenized fund offerings on the Sei Network by bringing access to Hamilton Lane's (NASDAQ:HLNE) Senior Credit Opportunities Fund ("SCOPE") onchain, via HL SCOPE Access Fund1, for institutional and accredited inv

    10/15/25 9:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated to Announce Second Quarter Fiscal 2026 Results on November 4, 2025

    CONSHOHOCKEN, Pa., Oct. 14, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the second fiscal quarter ended September 30, 2025 before the market opens on Tuesday, November 4, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 10:00 a.m. ET on November 4 to discuss the results for the second fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://shareholders.hamiltonlane.com/) at lea

    10/14/25 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Novata Acquires Atlas Metrics to Power the Future of Sustainability Data Management

    Backed by a new funding round led by S&P Global, Novata is defining the next era of sustainability data for private markets Novata, a leading sustainability data management platform for private markets, today announced the acquisition of Atlas Metrics, a top European sustainability performance and reporting platform. This strategic move expands Novata's global reach and unites two complementary companies to meet the growing demand from investors and corporates for trusted, efficient, and scalable sustainability data solutions. Together, Novata and Atlas Metrics now supports more than 400 clients and 13K+ companies worldwide, equipping investors, banks, and corporates with the tools th

    10/7/25 7:10:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/13/24 9:56:40 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/12/24 3:55:46 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/4/24 11:53:29 AM ET
    $HLNE
    Investment Managers
    Finance